Episode Details
Back to EpisodesQ&A with Poolbeg Pharma CEO, Jeremy Skillington
Episode 2105
Published 9 months, 3 weeks ago
Description
Watch on YouTube
Following on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
Following on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.